Hunan Hansen Pharmaceutical Co Ltd Long-term Investment Intensity

Latest as of September 2019: 29.9%

Hunan Hansen Pharmaceutical Co Ltd long-term investment intensity. Hunan Hansen Pharmaceutical Co Ltd (002412) has a Long-term Investment Intensity of 29.9% as of September 2019. Long-term investments of CN¥566.09 Million represent 29.9% of total assets of CN¥1.90 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read Hunan Hansen Pharmaceutical Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.

LT Investment Intensity

29.9%
LT Investments / Total Assets

Long-term Investments

CN¥566.09 Million
CNY

Total Assets

CN¥1.90 Billion
CNY

Country

China
SHE

Long-term Investment Intensity of Hunan Hansen Pharmaceutical Co Ltd (2016–2018)

Long-term investment intensity of Hunan Hansen Pharmaceutical Co Ltd from 2016 to 2018. This chart shows how Hunan Hansen Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 3 annual periods from 2016 to 2018. As of September 2019, the intensity stands at 29.9%, reflecting long-term investments of CN¥566.09 Million against total assets of CN¥1.90 Billion CNY.

Hunan Hansen Pharmaceutical Co Ltd Long-term Investment Intensity by Year (2016–2018)

Hunan Hansen Pharmaceutical Co Ltd long-term investment intensity by year from 2016 to 2018. The table below presents the year-by-year Long-term Investment Intensity for Hunan Hansen Pharmaceutical Co Ltd from 2016 to 2018, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 002412 asset base.

Year LT Investment Intensity LT Investments (CNY) Total Assets Change (pp)
2018 29.9% CN¥537.57 Million CN¥1.80 Billion ▲ +3.4 pp
2017 26.5% CN¥450.37 Million CN¥1.70 Billion ▼ -0.1 pp
2016 26.5% CN¥444.44 Million CN¥1.67 Billion —
pp = percentage points